As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.
Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...
But in announcing the cuts, 23andMe CEO Anne Wojcicki said her goal is to ensure the "long-term success" of its core consumer ...
Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company ...